Author:
Bryant Henry U.,Glasebrook Andrew L.,Yang Na N.,Sato Masahiko
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism
Reference80 articles.
1. Lindsay R, Aitken JM, Anderson JB (1976) Long-term prevention of post-menopausal osteoporosis by estrogen. Lancet 1:1038–1041
2. Stampfer MJ, Colditz GA, Willet WC, Manson JE, Rosner B, Speizer FE, Hennekens CH (1991) Post-menopausal estrogen therapy, and cardiovascular disease: Ten-year follow-up from the nurses health study. N Engl J Med 325:756–762
3. Wiznitzer I, Benz C (1983) Tamoxifen vs. LY156758 for treatment of human breast and prostate cancer in vitro (abstract). Breast Cancer Res Treat. 3:305
4. Wakeling AE, Valcaccia B, Newboult E, Green LR (1984) Non-steroidal antioestrogens—receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells. J Steroid Biochem 20:111–120
5. Sato M, Glasebrook AL, Bryant HU (1995) Raloxifene: A selective estrogen receptor modulator. J Bone Miner Met 12 [Suppl II]:S9-S20
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献